Patents

Newsletter January 2022
Fabian Lieb
Patents
 German Patent Act
Injunctions: reducing the gap and the hardship - 31 months for German phase entry The German (...)
Newsletter January 2022
Isabelle Labarre
Patents, Biology Chemistry
Patent Term Extension
On June 01, 2021, the fourth amendment of Patent Law in China entered into effect.  This amendment (...)
Newsletter January 2022
Laurence Loumes
Patents
pacte law
In 2019, a series of new laws came into force with the goal of strengthening the French economy. (...)
Events & Conferences
Laurence Loumes
Patents
Plasseraud IP at the EU-Japan Innovation Day
Meet our experts Atsuya TAKESHITA, Japanese Patent Attorney, and Laurence Loumes, European Patent (...)
Events & Conferences
Ina Schreiber, Fabian Lieb
Patents
Plasseraud IP speaks about the French patent law reform in Germany
The French patent law reform, loi PACTE: from evolution to practice.   In application since January (...)
Events & Conferences
Patents, Trademarks & Designs
Plasseraud IP at the AIPPI International Congress
Cyra Nargolwalla, Guylène Kiesel Le Cosquer, and Frédéric Glaize, Partners at Plasseraud IP, and (...)
Newsletter September 2021
Mathias Robert
Patents
Patent eligibility
Artificial intelligence enables machines to learn from experience and mimic human behavior on (...)
Laurence Loumes
Patents
certificat d’utilité
The French utility model “certificat d’utilité” (literally utility certificate) is a property title (...)
Article
Laurence Loumes , Mathias Robert
Patents, Mechanics - Electronics - IT
patent eligibility
The first hurdle to patent an invention in the USA is to pass the patent eligibility bar of 35 U.S. (...)
Newsletter June 2021
Atom Tong Xi Jun
Patents
Chinese patent law
China is one of the most dynamic and promising economies in the world. In order to meet the demands (...)
Events & Conferences
Nadine Rocaboy
Patents, Trademarks & Designs, Start-up
VivaTech
Plasseraud IP is pleased to be participating in the 5th edition of Viva Technology, the largest (...)
Article
Mathias Robert, Denis Bourgarel
Patents, Mechanics - Electronics - IT, Biology Chemistry
Artificial Intelligence and Drug Development
Artificial intelligence (AI), like any other previous General Purpose Technology, is pervasive, (...)